BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38590969)

  • 1. Papillary renal neoplasm with reverse polarity has low frequency of alterations in chromosomes 7, 17, and Y.
    Kiyozawa D; Iwasaki T; Takamatsu D; Kohashi K; Miyamoto T; Fukuchi G; Eto M; Yamashita M; Oda Y
    Virchows Arch; 2024 Jun; ():. PubMed ID: 38877360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation.
    Han H; Yin SY; Song RX; Zhao J; Yu YW; He MX; Wang H
    Transl Androl Urol; 2024 Mar; 13(3):383-396. PubMed ID: 38590969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary renal neoplasm with reverse polarity: A clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity.
    Shen M; Yin X; Bai Y; Zhang H; Ru G; He X; Teng X; Chen G; Zhao M
    Front Oncol; 2022; 12():930296. PubMed ID: 35936734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
    Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
    Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Papillary renal neoplasm with reverse polarity: a clinicopathological analysis].
    Ji RH; Wang XT; Li R; Ye SB; Wang X; Ma HH; Lu ZF; Rao Q; Xia QY
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):23-27. PubMed ID: 34979749
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
    Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
    Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma.
    Liu Y; Zhang H; Li X; Wang S; Zhang Y; Zhang X; Xu T; Dong Y; Dong L; Zhou L; Yang X; Wang C
    Hum Pathol; 2022 Sep; 127():78-85. PubMed ID: 35724772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.
    Ricci C; Ambrosi F; Franceschini T; Giunchi F; Grillini A; Franchini E; Grillini M; Schiavina R; Massari F; Mollica V; Tateo V; Bianchi FM; Bianchi L; Droghetti M; Maloberti T; Tallini G; Colecchia M; Acosta AM; Lobo J; Trpkov K; Fiorentino M; de Biase D
    Virchows Arch; 2023 Nov; 483(5):687-698. PubMed ID: 37845471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiT/TFE Family Renal Cell Carcinoma.
    Tang J; Baba M
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary renal cell neoplasm with reverse polarity: A new subtype of renal tumour with favorable prognosis.
    Conde-Ferreirós M; Domínguez-de Dios J; Juaneda-Magdalena L; Bellas-Pereira A; San Miguel Fraile MP; Peteiro Cancelo MÁ; Gómez-de María C; Álvarez Sarria M; Betancor Santos MÁ; González-Carreró J; Ortiz-Rey JA
    Actas Urol Esp (Engl Ed); 2022 Dec; 46(10):600-605. PubMed ID: 36216763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity.
    Williamson SR; Hes O; Trpkov K; Aggarwal A; Satapathy A; Mishra S; Sharma S; Sangoi A; Cheng L; Akgul M; Idrees M; Levin A; Sadasivan S; San Miguel Fraile P; Rogala J; Comperat E; Berney DM; Bulimbasic S; McKenney JK; Jha S; Sampat NY; Mohanty SK
    Histopathology; 2023 Jan; 82(2):296-304. PubMed ID: 36208048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary Renal Neoplasm With Reverse Polarity: A Clinical, Pathologic, and Molecular Study of 8 Renal Tumors From a Single Institution.
    Nova-Camacho LM; Martin-Arruti M; Díaz IR; Panizo-Santos Á
    Arch Pathol Lab Med; 2023 Jun; 147(6):692-700. PubMed ID: 36170616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary renal neoplasm with reverse polarity may be a novel renal cell tumor entity with low malignant potential.
    Yang T; Kang E; Zhang L; Zhuang J; Li Y; Jiang Y; Wang H; Yu W; Zhang W
    Diagn Pathol; 2022 Aug; 17(1):66. PubMed ID: 36002896
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.